Earnings Feed
Start Free
Home/Filings/4/A/0000893838-06-000058
4/A//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4/A

Accession 0000893838-06-000058

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

May 3, 8:00 PM ET

Accepted

May 4, 8:50 PM ET

Size

16.6 KB

Accession

0000893838-06-000058

Insider Transaction Report

Form 4/AAmended
Period: 2005-09-12
REXAHN PHARMACEUTICALS, INC.RXHN
HOLADAY JOHN W DR
Director
Transactions
  • Disposition to Issuer

    Stock option (right to buy)

    2006-05-02−125,000→ 0 total
    Exercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying)
  • Award

    Stock option (right to buy)

    2006-05-02+125,000→ 125,000 total
    Exercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying)
  • Award

    Stock option (right to buy)

    2006-05-02+70,000→ 70,000 total
    Exercise: $0.80Exp: 2013-08-05→ Common stock (70,000 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2006-05-02−70,000→ 0 total
    Exercise: $0.80Exp: 2013-08-05→ Common stock (70,000 underlying)
  • Award

    Stock option (right to buy)

    2006-05-02+20,000→ 20,000 total
    Exercise: $3.00Exp: 2015-09-12→ Common stock (20,000 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2006-05-02−20,000→ 0 total
    Exercise: $3.00Exp: 2015-09-12→ Common stock (20,000 underlying)
Footnotes (3)
  • [F1]Pursuant to an agreement dated May 2, 2006, all of Dr. Holaday's options vest and become exercisable immediately upon his termination of service as director of Rexahn Pharmaceuticals, Inc. and may be exercised until 10 years after the original date of grant.
  • [F2]Original Form 4 reported 05/02/2016 as the Date Exercisable due to clerical error.
  • [F3]The transaction involved an amendment of outstanding options to accelerate vesting and extend the exercise period pursuant to an agreement dated May 2, 2006, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4/A
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:50 PM ET
Size
16.6 KB
View on SEC.gov